Search results for "anticoagulants"

showing 10 items of 236 documents

The control of anti-coagulation in acute dialyses with sensitive laboratory parameters.

1992

In seven patients who had to be dialysed between four and 13 times due to acute renal failure, low molecular weight heparin (LMWH) Fragmin was used for anticoagulation. According to dose-finding studies, 80-90 U kg-1 body weight of LMWH as a single bolus were administered initially, producing dose-related levels of 0.3-1.5 anti-factor Xa U ml-1 in plasma. Apart from the anti-Xa activity in the plasma, the thrombin anti-thrombin III complex (TAT complex) and a fibrin degradation product (D-dimer) were measured as parameters of a coagulation activation. A sufficient anti-coagulation during dialysis was supposed to exist at a normal range (5.0 micrograms l-1 or below) of TAT complex. Pathologi…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentClinical BiochemistryAntithrombin IIILow molecular weight heparinPharmacologyFibrin Fibrinogen Degradation ProductsThrombinRenal DialysisD-dimermedicineHumansBlood CoagulationDialysisAgedFibrin degradation productbusiness.industryAnticoagulantExtracorporeal circulationAnticoagulantsGeneral MedicineHeparinAcute Kidney InjuryHeparin Low-Molecular-WeightMiddle AgedSurgerybusinessmedicine.drugFactor Xa InhibitorsPeptide HydrolasesScandinavian journal of clinical and laboratory investigation
researchProduct

Ten-year outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Ar…

2000

The 10-year results of randomized trials comparing percutaneous transluminal coronary angioplasty (PTCA) in patients with single-vessel coronary artery disease (CAD) with coronary artery bypass grafting (CABG) and medical treatment are not available yet. The aim of this evaluation was to compare our 10-year follow-up results after PTCA in patients with single-vessel CAD with the 10-year follow-up results after CABG and medical treatment in the Coronary Artery Surgery Study (CASS) trial. We evaluated the clinical outcome of 509 patients with single-vessel CAD 10 years after coronary angioplasty. The data were compared with the results of 214 patients with single-vessel CAD after CABG or medi…

Malemedicine.medical_specialtymedicine.medical_treatmentAdrenergic beta-AntagonistsCoronary DiseaseBalloonDisease-Free Survivallaw.inventionCoronary artery diseaseNitroglycerinRandomized controlled triallawAngioplastyInternal medicineGermanySurveys and QuestionnairesmedicineHumanscardiovascular diseasesMyocardial infarctionDerivationAngioplasty Balloon CoronaryCoronary Artery BypassHypolipidemic Agentsbusiness.industryAnticoagulantsMiddle Agedmedicine.diseaseCalcium Channel BlockersSurvival AnalysisSurgerysurgical procedures operativemedicine.anatomical_structureTreatment OutcomeBypass surgeryCardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryFollow-Up StudiesThe American journal of cardiology
researchProduct

Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.

2014

Background Hemorrhagic transformation (HT), a complication of ischemic stroke (IS), might influence patient's prognosis. Our aim is to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and mortality. Methods We compared mortality of individuals with spontaneous HT with that of individuals without. Medical records of patients diagnosed with anterior IS were retrospectively reviewed. Outcome measures were 30- and 90-day survival after IS onset. Kaplan–Meier estimates were used to construct survival curves. Cox proportional hazards model was used to estimate hazard ratio (HR) for the main outcome measure (death). HT was stratified in he…

Malemedicine.medical_specialtysurvivalBrain IschemiaCohort StudiesHematomaRisk FactorsInternal medicineMedicineHumansStrokeSurvival analysisAgedRetrospective StudiesAged 80 and overIschemic strokeAspirinbusiness.industryProportional hazards modelHeparinMortality rateRehabilitationHazard ratioAnticoagulantsIschemic stroke; epidemiology; hemorrhagic transformation; prognosis; survivalMiddle Agedmedicine.diseaseConfidence intervalSurgeryStrokeSurvival Ratehemorrhagic transformationCardiologyDisease ProgressionepidemiologySettore MED/26 - NeurologiaSurgeryFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessComplicationIntracranial HemorrhagesprognosiPlatelet Aggregation InhibitorsFollow-Up StudiesJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.

2017

Background and Purpose— Selective serotonin-reuptake inhibitors (SSRIs) impair platelet function and have been linked to a higher risk of spontaneous intracerebral hemorrhage—an association that may be augmented by oral anticoagulants (OAC). We aimed to assess whether preadmission treatment with SSRIs in patients with acute ischemic stroke is associated with post-thrombolysis symptomatic intracerebral hemorrhage (sICH) and functional outcome. Methods— A multicenter retrospective analysis was conducted in prospective registries of patients treated by thrombolysis within 4.5 hours of stroke onset. The association between preadmission treatment with SSRIs and sICH (ECASS II definition [Europe…

Malemedicine.medical_specialtytherapeutic use [Anticoagulants]medicine.medical_treatmentSubgroup analysisepidemiology [Cerebral Hemorrhage]Risk AssessmentCohort Studies03 medical and health sciencesadverse effects [Serotonin Uptake Inhibitors]0302 clinical medicineModified Rankin ScaleInternal medicinemedicineHumansThrombolytic Therapy030212 general & internal medicineddc:610610 Medicine & healthStrokeCerebral HemorrhageAgedRetrospective StudiesAdvanced and Specialized NursingIntracerebral hemorrhageAged 80 and overtherapy [Cerebral Hemorrhage]business.industryAnticoagulantsThrombolysisOdds ratioMiddle Agedmedicine.diseaseadverse effects [Selective Serotonin Reuptake Inhibitors]Prognosisdrug therapy [Stroke]StrokeTreatment OutcomeAnesthesiaConcomitantSerotonin Uptake InhibitorsFemaleNeurology (clinical)Cardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgerySelective Serotonin Reuptake Inhibitorsepidemiology [Stroke]Cohort study
researchProduct

Safety of endovascular treatment in acute stroke patients taking oral anticoagulants

2017

International journal of stroke 12(4), 412-415 (2017). doi:10.1177/1747493016677986

Maletherapeutic use [Anticoagulants]medicine.medical_specialtyMedizinAdministration Oral030204 cardiovascular system & hematologyBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineetiology [Intracranial Hemorrhages]Modified Rankin ScaleInterquartile rangeAntithromboticmedicineHumansThrombolytic Therapyddc:610Prospective StudiesRegistriesadverse effects [Anticoagulants]Prospective cohort studyStrokeAgedAged 80 and overbusiness.industryConfoundingAnticoagulantsmethods [Thrombolytic Therapy]complications [Brain Ischemia]Middle Agedmedicine.diseasedrug therapy [Stroke]Surgerysurgery [Stroke]StrokeTreatment Outcomeadministration & dosage [Anticoagulants]Neurologydrug therapy [Brain Ischemia]FemaleObservational studydrug therapy [Intracranial Hemorrhages]businessIntracranial Hemorrhages030217 neurology & neurosurgery
researchProduct

Central retinal artery occlusion-A new, provisional treatment approach.

2019

The retinal ganglion cells infarcted in central retinal artery occlusion (CRAO) are the somata of the optic nerve axons, part of the central nervous system. Consequently, CRAO with inner retinal infarction is a small vessel stroke, usually with the devastating consequence of severe visual loss in the affected eye. At present, there is no generally accepted, evidence-based therapy of nonarteritic CRAO in contrast to ischemic cerebral stroke that has well-accepted treatment protocols. Widely divergent and controversial therapeutic options for CRAO reflect the desperation of treating physicians and disparate conflicting studies. We examine reasons why treatment of nonarteritic CRAO remains pro…

MassageRetinal Ganglion Cellsmedicine.medical_specialtybusiness.industryRetinal Artery OcclusionAnticoagulantsCherry-red spotCerebral strokemedicine.diseaseRetinal ganglionOphthalmologyFibrinolytic AgentsOphthalmologyOptic nerveMedicineCentral retinal artery occlusionHumansSmall vesselmedicine.symptombusinessStrokeAntihypertensive AgentsIntraocular PressureRetinal infarctionSurvey of ophthalmology
researchProduct

Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review

2021

Atrial fibrillation (AF) is the most common arrhythmia in chronic kidney disease (CKD), with a close bidirectional relationship between the two entities. The presence of CKD in AF increases the risk of thromboembolic events, mortality and bleeding. Vitamin K antagonists (VKA) have been the mainstay of treatment for the prevention of thromboembolic events in AF until recently, with confirmed benefits in AF patients with stage 3 CKD. However, the risk-benefit profile of VKA in patients with AF and stages 4–5 CKD is controversial due to the lack of evidence from randomized controlled trials. Treatment with VKA in CKD patients has been associated with conditions such as poorer anticoagulation q…

Medicine (General)medicine.medical_specialtyVitamin KMini ReviewLower riskurologic and male genital diseaseslaw.inventionDirect oral anticoagulantsR5-920Randomized controlled triallawInternal medicineFibril·lació auricularMalalties cròniquesMedicineatrial fibrillationStrokeCalciphylaxisKidney diseasesbusiness.industryWarfarinAcute kidney injuryanticoagulant-related nephropathyAtrial fibrillationGeneral Medicinemedicine.diseaseVitamines KAtrial fibrillationfemale genital diseases and pregnancy complicationsVitamin K antagonistsArítmiaChronic diseasesInsuficiència renal crònicaAnticoagulants (Medicina)CardiologyMalalties del ronyóMedicineAnticoagulants (Medicine)businesschronic kidney diseasemedicine.drugKidney diseaseFrontiers in Medicine
researchProduct

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion

2019

Atrial fibrillation the most common cardiac arrhythmia. Its incidence rises steadily with each decade, becoming a real “epidemic phenomenon”. Cardioversion is defined as a rhythm control strategy which, if successful, restores normal sinus rhythm. This, whether obtained with synchronized shock or with drugs, involves a periprocedural risk of stroke and systemic embolism which is reduced by adequate anticoagulant therapy in the weeks before or by the exclusion of left atrial thrombi. Direct oral anticoagulants are safe, manageable, and provide rapid onset of oral anticoagulation; they are an important alternative to heparin/warfarin from all points of view, with a considerable reduction in b…

Medicine (General)medicine.medical_specialtymedicine.medical_treatmentElectric CountershockAdministration OralReviewCardioversionDrug Administration ScheduleR5-920Quality of lifeInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseaseselectrical cardioversion (ec)Strokedirect oral anticoagulants (doacs)business.industryWarfarinAnticoagulantsCardiac arrhythmiaAtrial fibrillationGeneral MedicineHeparinmedicine.diseaseatrial fibrillation (af)Shock (circulatory)cardiovascular systemCardiologymedicine.symptombusinessmedicine.drugMedicina
researchProduct

Blood Anticoagulant Activity of Sulphated Ovular Mucins of Amphibians

1957

THE mucin constituting the gelatinous layer which envelops the eggs of Bufo bufo, if digested with papain and then sulphated, shows a marked anticoagulant activity on the fibrinogen and the whole blood plasma1. A similar anticoagulant activity has now been shown by the ovular mucins of other species of amphibians, sulphated without any previous proteolysis.

Multidisciplinarybiologymedicine.diagnostic_testSulfatesurogenital systemChemistryProteolysisMucinMucinsAnticoagulantsFibrinogenbiology.organism_classificationAnticoagulant activityAmphibiansPapainchemistry.chemical_compoundBiochemistrymedicineAnimalsHumanssense organsBufohormones hormone substitutes and hormone antagonistsmedicine.drugWhole bloodNature
researchProduct

Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience

2000

Vascular complications remain a significant nonimmunologic source of pancreas allograft loss. From February 1993 through January 1998, we performed 98 simultaneous pancreas-kidney transplantations (SPK) using pancreatic exocrine bladder drainage in patients with type 1 insulin-dependent diabetes mellitus and end-stage renal disease. They originally received quadruple immunosuppression, and since May 1997 triple immunosuppression protocol (tacrolimus, mycophenolate mofetil, and steroids). The patients' mean age was 37 years (range 24-53 years), including 50 women and 48 men with a mean follow-up of 42 months. The overall rate of vascular complications was 6% (5 patients). The vascular compli…

NephrologyAdultMalemedicine.medical_specialtyTime FactorsUrinary BladderArteriovenous fistulaHospitals UniversityPseudoaneurysmMesenteric VeinsPostoperative ComplicationsMesenteric Artery Superiormedicine.arteryInternal medicinemedicineHumansDiabetic NephropathiesSuperior mesenteric arteryVascular DiseasesSuperior mesenteric veinRetrospective StudiesVenous ThrombosisTransplantationbusiness.industryAnticoagulantsMiddle Agedmedicine.diseaseThrombosisKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Splenic veinFloridaKidney Failure ChronicDrug Therapy CombinationFemalePancreas TransplantationPancreasbusinessAneurysm FalseImmunosuppressive AgentsSpleenTransplant International
researchProduct